Forget buy-to-let, these FTSE 250 stocks are how I’d invest in property

Real Estate Investment Trusts can be a great way to invest in property with lowered risk. Here are two I like the look of in 2019.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

As a buy-to-let investor myself, squeezed rental yields and tougher regulations would stop me entering the business today. But the property sector still seems attractive to me, with a REIT-based approach looking a lot safer.

Health rental

While the FTSE 250 as a whole has gained 17.5% over the past five years, Primary Health Properties (LSE: PHP) has come close to doubling that with a gain of 33.7%.

The company invests in purpose-built healthcare facilities in the UK and Ireland, and I see that as a serious long-term growth business.

Earnings can be a bit erratic over the short term, but Primary Health has put in some solid long-term growth. That’s now translated into an impressive 22 successive years of dividend growth, after the 2018 dividend was lifted by 2.9% to 5.4p per share (which is comfortably ahead of inflation).

With clear income visibility, the bulk of its earnings are paid out as dividends, and yields are currently standing at around 5%.

The value of the firm’s investment portfolio rose by 2.5% in 2018, with its contracted rent roll up 9.8% and net rental income up 7.2%.

Merger

The overshadowing event in 2019 so far, however, is the proposal to merge with MedicX in an all-share deal “to create one of the largest healthcare REITs in the UK with a portfolio of over 470 assets valued at £2.3bn.” It needs approval from both sets of shareholders, but if that’s achieved then it should be completed in late March.

Both look solid to me, and I can see the combined business as being a great provider of long-term income — with further growth thrown in too.

Commercial

Last time I looked at New River Retail (LSE: NRR), its shares were down in the dumps, and they dipped further by the end of 2018 before putting in a very modest uptick.

The price is still down 30% over the past two years, but I guess that’s what happens to a REIT that invests in commercial properties (including the retail sector, like shopping centres) when the high street is suffering.

But it’s still managed an impressive recent record of earnings growth, as EPS has soared from 5.2p in 2014 to 16p for the year ended March 2018. And there’s more growth on the cards, with forecasts suggesting EPS of 20.5p by 2021.

That’s translated into a rapidly-growing dividend too, with yields of around 10% currently forecast for this year and the next two.

Strengths

A third-quarter update earlier in January reiterated New River’s key strengths, showing a high level of retail occupancy of 95.5%. That was down a little from 96.2% in September, though that was put down in part to a move by JD Sports at Priory Meadow, Hastings.

Average rents were down slightly, to £12.37 per square foot from £12.48, and the firm had collected an impressive 99.6% of its due rents by the time of the announcement.

With the share price having fallen so far, P/E ratios now stand at around 10-11.5, and I can’t help feeling that an upwards share price correction is due.

I doubt it will happen quickly, mind, as we’re surely heading for further retail turmoil in 2019, however badly Brexit turns out. But I’m seeing a solid long-term property buy here.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has recommended Primary Health Properties. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »